Welcome to our dedicated page for Art's-Way Manufacturing news (Ticker: ARTW), a resource for investors and traders seeking the latest updates and insights on Art's-Way Manufacturing stock.
Art's-Way Manufacturing Co., Inc. reports company developments tied to its agricultural equipment business and its Modular Buildings segment serving livestock and research needs. News releases commonly cover quarterly and fiscal results, sales trends, backlog, demand conditions in agricultural products, and profitability contributions from modular building projects.
The company's updates also reference balance sheet and cash flow priorities, tariff and farm-sector conditions, and completed corporate actions such as the wind-down of its former Tools segment. Coverage centers on how its two continuing business units perform across agricultural and research end markets.
Art's Way (Nasdaq:ARTW) reported that its Modular Buildings segment has recently been awarded major projects, increasing segment backlog to over $19.0 million, compared with $1.3 million reported in its Form 10-Q for the fiscal quarter ended May 31, 2026.
According to Art's Way, these awards significantly expand production commitments and improve visibility into future manufacturing activity. The backlog is currently estimated to be substantially fulfilled by the end of the Company’s 2027 fiscal year, subject to customer schedules, project milestones and execution. The Company expects these projects to be executed at margins generally consistent with historical Modular Buildings performance, while emphasizing that backlog, defined as the value of signed contracts not yet completed, is not necessarily indicative of future revenue or its timing.
Art's Way (NASDAQ:ARTW) reported strong year-to-date results for the six months ended May 31, 2026, with consolidated sales up 26.3% and operating income up 20.2% versus 2025.
Net income was $370,000 (EPS $0.07), compared with higher prior-year earnings that benefited from a one-time Employee Retention Credit. Modular Buildings drove growth, while gross margins faced input cost pressure.
Art's Way Manufacturing (Nasdaq:ARTW) announced that its wholly owned subsidiary Art's Way Scientific and longtime president and director of sales Dan Palmer were honored at the 2026 World of Modular Awards of Distinction.
The company received Alternate (second place) in the Healthcare – Permanent category for its MD Anderson Cancer Research Center modular vivarium project.
Art's-Way Manufacturing (Nasdaq:ARTW) reported a strong start to fiscal 2026 with consolidated sales up 29.2% and net income of $196,000 for Q1 (Feb 28, 2026), versus a loss a year earlier. Agricultural sales rose 27.3% and Modular Buildings sales rose 31.6%, while consolidated gross margin dipped slightly and modular margins narrowed.
The company cited stronger demand, robust backlog in modular buildings, rising steel costs, and mixed crop-specific trends that include a 63% decline in beet orders.
Art's Way (Nasdaq:ARTW) reported fiscal 2025 results with consolidated sales of $22.975M, down 6.2% from fiscal 2024, and net income from continuing operations of $1.035M. Operating expenses fell ~12.7% and EPS was $0.20 vs a loss of $0.02 prior year.
Modular Buildings grew sales 4.0% to $10.226M and remained profitable; Agricultural Products sales fell 13.1% to $12.749M. An Employee Retention Credit refund materially boosted 2025 net income.
Art's Way Manufacturing (Nasdaq:ARTW) reported Q3 fiscal 2025 consolidated sales of $6.43M (up 9.5% vs Q3 2024) and nine‑month sales of $17.91M (down 2.3% YoY). Nine‑month consolidated gross margin improved 1.2 percentage points and net income for the nine months was $1.68M, a $2.11M improvement aided by an Employee Retention Credit refund of $1.154M. Modular Buildings drove growth: Q3 sales +19.4% and nine‑month sales +21.4% with nine‑month gross margin +8.9pts. Agricultural Products saw weakness: nine‑month sales down 15.5% and gross margin down 3.4pts. Management cites inventory headwinds, higher steel/tariff costs, a planned 3–5% price pass‑through, and cautious optimism for improvement in 9–15 months.
Art's Way Manufacturing (NASDAQ:ARTW) reported its Q2 2025 financial results, demonstrating improved profitability despite challenging agricultural market conditions. The company posted Q2 2025 sales of $6.34M, a 5.8% decline from Q1 2024, while achieving net income of $1.43M for the first six months of 2025, including a $1.15M Employee Retention Credit refund.
The Agricultural Products segment saw sales decline 11.6% to $4.03M in Q2 2025, while the Modular Buildings segment grew 6.3% to $2.31M. The company successfully reduced operating expenses by 15.3% in the first half of 2025 and improved six-month gross profit by 3.8% compared to 2024. Earnings per share reached $0.28 for the first six months of 2025, compared to a loss of $0.09 in 2024.
[ "Net income improved by $1.86M to $1.43M for first six months of 2025", "Operating expenses reduced by 15.3% in first half of 2025", "Modular Buildings segment sales increased 23% in first six months of 2025", "Gross profit improved 3.8% in first half of 2025", "Strong performance in grinder mixer sales due to record high livestock prices" ]Art's Way Manufacturing (ARTW) reports Q1 2025 financial results showing mixed performance across segments. Overall sales declined 10.2% to $5.14 million, but the company achieved a 3.4% gross profit improvement and 19.4% reduction in operating expenses compared to Q1 2024.
The Agricultural Products segment faced challenges with sales dropping 30.4% to $2.95 million, primarily due to high interest rates and low commodity prices. However, the company maintains stable gross margins through cost-cutting measures implemented in 2024.
The Modular Buildings segment showed strong growth with sales increasing 47.5% to $2.19 million and net income improving by $262,000 to $291,000. The segment benefits from a robust backlog and continued strong demand.
Overall net loss narrowed to $56,000 ($0.01 per share) in Q1 2025, a significant improvement from the $368,000 loss in Q1 2024. Management remains optimistic despite market uncertainties, citing potential interest rate cuts and improving dealer inventory levels as positive indicators.
Art's-Way Manufacturing (NASDAQ:ARTW) has reported mixed financial results for fiscal 2024. The Agricultural Products segment saw a 34.7% decrease in net sales to $14.66M, driven by below-average commodity prices and decreased demand. However, the Modular Buildings segment showed strong performance with a 25.9% increase in net sales to $9.84M, particularly in research markets.
The company reported consolidated operating income from continuing operations of $461,000, down from $1.53M in 2023. The Agricultural Products segment posted an operating loss of $1.51M, while Modular Buildings achieved operating income of $1.97M. Overall consolidated net income was $307,000, slightly up from $267,000 in 2023.
Current backlog stands at $3.49M for Agricultural Products and $2.39M for Modular Buildings as of February 4, 2025. The company completed the sale of its discontinued Tools segment real estate for $1.8M in October 2024. Management expects improved profitability in 2025, citing positive indicators in dairy and livestock markets and sustained momentum in the Modular Buildings segment.
Art's Way Manufacturing Co., Inc. (Nasdaq:ARTW) reports financial results for Q3 fiscal 2024 and announces CEO transition. Consolidated sales from continuing operations decreased 27.6% to $5,876,000 for Q3 and 21.8% to $18,329,000 for the nine months ended August 31, 2024. The Agricultural Products segment saw a 46% decrease in Q3 sales, while the Modular Buildings segment increased 11.6%.
Net income from continuing operations was $2,000 for Q3, compared to $241,000 in fiscal 2023. For the nine-month period, the company reported a net loss of $427,000. Loss per share for Q3 was $0.00, compared to income of $0.05 in 2023.
Effective October 1, 2024, President and CEO David King has mutually agreed to separate from the company. Chairman Marc McConnell will serve as the new President and CEO.